Thus, although the impact of the CCL21/CCR7 signaling on anti-tumor immunity remains controversial, the fact that CCL21 expression can induce an immune response provides a rationale for the use of CCL21 in cancer immunotherapy. The gene discussed is CCR7; the disease is cancer.